Tanya Simuni

MedicineHealth ProfessionsNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.3Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433

Top 12%

1.7DataRank

Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Papers

Driven by 41 papers — median percentile 75. Top paper: “Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression”.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

JAMA(2021)10.1001/jama.2021.10207

N/A

4.5DataRank · unranked

160 citations

Brent Bluett, Daniel M. Togasaki, Dragos Mihaila, Marian L. Evatt, Michael Rezak +95 more

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433

Top 12%

1.7DataRank

Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

Journal of Parkinson s Disease(2021)10.3233/jpd-212714

N/A

1.7DataRank · unranked

61 citations

on behalf of the MOVES-PD Investigators, Hidemoto Saiki, Taku Hatano, Thomas Gasser, Stuart Isaacson +17 more

Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial

Nature Medicine(2024)10.1038/s41591-024-03270-6

N/A

0.908DataRank · unranked

51 citations

Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda, Thomas Kustermann +17 more

Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts

npj Parkinson s Disease(2024)10.1038/s41531-024-00789-w

Top 25%

0.813DataRank

Top 25%37 citations

Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub +95 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

npj Parkinson s Disease(2022)10.1038/s41531-022-00404-w

Top 26%

0.783DataRank

Top 26%19 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +85 more

Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study

Movement Disorders Clinical Practice(2023)10.1002/mdc3.13751

N/A

0.688DataRank · unranked

11 citations

Marina Picillo, Hyunkeun Ryan Cho, Chelsea Caspell‐Garcia, Cornelis Blauwendraat, Ethan Brown +17 more

A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson’s Disease

UNC Libraries(2020)10.17615/9rw0-0941

N/A

0DataRank · unranked

0 citations

Jennifer G. Goldman, Alexander I. Tröster, Uc, Ergun Y., Karen Frei, Bonnie Levin +10 more

Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations

Journal of Parkinson s Disease(2021)10.3233/jpd-202472

N/A

0DataRank · unranked

136 citations

Seyed-Mohammad Fereshtehnejad, Daniela Berg, Nicolaas I. Bohnen, Kathy Dujardin, Roberto Erro +19 more

A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson’s Disease

Journal of Parkinson s Disease(2021)10.3233/jpd-202381

N/A

0DataRank · unranked

32 citations

Ruth B. Schneider, Tanya Simuni, Danielle Larson

Seeking progress in disease modification in Parkinson disease

Parkinsonism & Related Disorders(2021)10.1016/j.parkreldis.2021.09.006

N/A

0DataRank · unranked

15 citations

Jesse M. Cedarbaum, Ted M. Dawson, E. Ray Dorsey, Carlos Alberto Faraco, Howard J. Federoff +18 more

Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease

Movement Disorders(2021)10.1002/mds.28641

N/A

0DataRank · unranked

5 citations

Kelly A. Mills, Shirley Eberly, David Oakes, Kelvin L. Chou, Matthew Halverson +9 more

The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults

Journal of Communication Disorders(2021)10.1016/j.jcomdis.2021.106149

N/A

0DataRank · unranked

3 citations

Ellen Herschel, Katharine Aveni, Kris Tjaden, Todd B. Parrish, Tanya Simuni +3 more

Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy

NeuroImage Clinical(2022)10.1016/j.nicl.2022.103022

N/A

0DataRank · unranked

37 citations

Bradley J. Wilkes, Derek B. Archer, Winston T. Chu, Stephen A. Coombes, Song Lai +14 more

Path to Parkinson Disease Prevention

Neurology(2022)10.1212/wnl.0000000000200793

N/A

0DataRank · unranked

33 citations

Grace F. Crotty, Jessi L. Keavney, Michael A. Schwarzschild, Tanya Simuni, Caroline Tanner +1 more

Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy

Movement Disorders(2022)10.1002/mds.29164

N/A

0DataRank · unranked

16 citations

Anja Tietz, Viktoria Ruf, Owen A. Ross, Shunsuke Koga, Dennis W. Dickson +67 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers: The PPMI cohort

Research Square(2022)10.21203/rs.3.rs-1719882/v1

N/A

0DataRank · unranked

3 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +11 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1

N/A

0DataRank · unranked

1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study

npj Parkinson s Disease(2023)10.1038/s41531-023-00497-x

N/A

0DataRank · unranked

92 citations

Tairmae Kangarloo, Brian Tracey, Patricio O’Donnell, Dmitri Volfson, Robert D. Latzman +77 more

A blood-based marker of mitochondrial DNA damage in Parkinson’s disease

Science Translational Medicine(2023)10.1126/scitranslmed.abo1557

N/A

0DataRank · unranked

84 citations

Esther Sammler, Claudia P. González-Hunt, Ivana Barraza, Nicholas Pena, Jeremy P. Rouanet +24 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2

N/A

0DataRank · unranked

42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more

Providing genetic testing and genetic counseling for Parkinson’s disease to the community

Genetics in Medicine(2023)10.1016/j.gim.2023.100907

N/A

0DataRank · unranked

31 citations

Jennifer Verbrugge, Tae‐Hwi Schwantes‐An, Jeanine Schulze, James C. Beck, Anna Naito +10 more

Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study

Brain(2024)10.1093/brain/awae142

N/A

0DataRank · unranked

93 citations

Jennifer Verbrugge, Tae‐Hwi Schwantes‐An, Jeanine Schulze, Tatiana Foroud, Anne Hall +31 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699

N/A

0DataRank · unranked

76 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000208033

N/A

0DataRank · unranked

23 citations

David J. Irwin, Thomas F. Tropea, Emma Rhodes, Jeffrey S. Phillips, Alice S. Chen-Plotkin +18 more

Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants

Journal of Parkinson s Disease(2024)10.3233/jpd-240015

N/A

0DataRank · unranked

18 citations

Samuel M. Goldman, Christopher S. Coffey, Andrew Siderowf, Tanya Simuni, Cheryl Meng +6 more

Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome

Movement Disorders Clinical Practice(2024)10.1002/mdc3.14089

N/A

0DataRank · unranked

6 citations

Daniel Weintraub, Tanya Simuni, Mayela Rodríguez‐Violante, Albert F.G. Leentjens, Joshua Shulman +8 more

LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates

medRxiv(2024)10.1101/2024.07.22.24310806

N/A

0DataRank · unranked

4 citations

David-Erick Lafontant, Seung Ho Choi, Hirotaka Iwaki, Cornelis Blauwendraat, Andrew Singleton +20 more

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia

medRxiv(2024)10.1101/2024.12.12.24318917

N/A

0DataRank · unranked

0 citations

Anuprita R Nair, Ryan Kurth, Michael C. Brumm, Michele K. York, Roseanne D. Dobkin +20 more

Neuronal alpha-Synuclein Disease stage progression over five years

medRxiv(2024)10.1101/2024.12.17.24319172

Top 100%

0DataRank

Top 100%0 citations

Caroline Gochanour, Anuprita R Nair, Michael C. Brumm, Christopher S. Coffey, Kathleen L. Poston +14 more

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives

Alzheimer s & Dementia(2025)10.1002/alz.70536

N/A

0DataRank · unranked

6 citations

Reisa A. Sperling, Alicia Algeciras‐Schimnich, Hidenori Arai, Anna M. Barron, Tammie L.S. Benzinger +39 more

Reply to: “Refutation of the αSyn ‐ SAA ‐Based Staging for Parkinson's Progression (Neuronal α‐Synuclein Disease‐Integrated Staging System [NSD ‐ ISS] )”

Movement Disorders(2025)10.1002/mds.30272

N/A

0DataRank · unranked

1 citations

Lana M. Chahine, Kathleen L. Poston, Catherine Kopil, Daniel Weintraub, Billy Dunn +2 more

Clinical and imaging characteristics of Parkinson’s disease with negative alpha-synuclein seed amplification assay

medRxiv(2025)10.1101/2025.10.01.25337085

N/A

0DataRank · unranked

1 citations

Jacopo Pasquini, Seung Ho Choi, David-Erick Lafontant, Seyed‐Mohammad Fereshtehnejad, Yashar Zeighami +25 more

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Movement Disorders(2020)10.1002/mds.28206

N/A

0DataRank · unranked

201 citations

Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg +21 more

Dermal Phospho-Alpha-Synuclein Among Individuals With and Without Cerebrospinal Fluid Aggregated Alpha-Synuclein

medRxiv(2025)10.64898/2025.12.17.25342090

N/A

0DataRank · unranked

0 citations

Krittika Chatterjee, Caroline Gochanour, David-Erick Lafontant, Rizwan Akhtar, Neil Shetty +16 more

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Annals of Neurology(2020)10.1002/ana.25811

N/A

0DataRank · unranked

111 citations

Janel Fedler, Christopher S. Coffey, Chelsea Caspell‐Garcia, Ju‐Hee Kang, Tanya Simuni +16 more

Role of data measurement characteristics in the accurate detection of Parkinson’s disease symptoms using wearable sensors

Journal of NeuroEngineering and Rehabilitation(2020)10.1186/s12984-020-00684-4

N/A

0DataRank · unranked

105 citations

Megan K. O’Brien, Sanjeev Venkatesan, Luca Lonini, Tanya Simuni, Jamie Hamilton +4 more

Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science

Digital Biomarkers(2020)10.1159/000512500

N/A

0DataRank · unranked

66 citations

Robert Alexander, Varun Aggarwal, Reham Badawy, Lisa J. Bain, Roopal Bhatnagar +37 more

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study

Parkinsonism & Related Disorders(2020)10.1016/j.parkreldis.2020.09.028

N/A

0DataRank · unranked

27 citations

Ruth B. Schneider, Marie Saint‐Hilaire, G. Webster Ross, Robert A. Hauser, Anthony E. Lang +9 more

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51164

N/A

0DataRank · unranked

40 citations

Pavlina Wolf, Ming Sum Ruby Chiang, Karolina Helesicova, Xiaokui Kate Zhang, Kalpana Merchant +15 more

Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51236

N/A

0DataRank · unranked

33 citations

Larsson Omberg, Eric A. Macklin, Margaret Daeschler, Lauren Bataille, Shalini Anthwal +26 more

Tanya Simuni

Indexed papers

Top data-sharing exemplar

Papers